Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials

Published:2018-10 Issue:10 Volume:19 Page:1338-1350
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Fang Wenfeng,Yang Yunpeng,Ma Yuxiang,Hong Shaodong,Lin Lizhu,He Xiaohui,Xiong Jianping,Li Ping,Zhao Hongyun,Huang Yan,Zhang Yang,Chen Likun,Zhou Ningning,Zhao Yuanyuan,Hou Xue,Yang Qing,Zhang Li

Funder

Chinese National Natural Science Foundation project

Science and Technology Program of Guangdong

Pearl River Nova Program of Guangzhou

Publisher

Elsevier BV

Subject

Oncology

Reference38 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Global trends in nasopharyngeal cancer mortality since 1970 and predictions for 2020: focus on low-risk areas;Carioli;Int J Cancer,2017

3. Nasopharyngeal carcinoma;Chua;Lancet,2016

4. Global trends in incidence and mortality of nasopharyngeal carcinoma;Tang;Cancer Lett,2016

5. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol,2015

Cited by 373 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial;Med;2024-09

2. Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma;Head & Neck;2024-08-12

3. A radiogenomic clinical decision support system to inform individualized treatment in advanced nasopharyngeal carcinoma;iScience;2024-08

4. The Association of Obstructive Sleep Apnea with Urological Cancer Incidence and Mortality—A Systematic Review and Meta-analysis;European Urology Focus;2024-08

5. Bibliometric analysis reveals the research hotspots and trends of nasopharyngeal carcinoma immunotherapy;Human Vaccines & Immunotherapeutics;2024-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3